Therefore, we evaluated this concept and found that combining U-Sed examination to urinary TIMP-2 and IGFBP7, urinary KIM-1 significantly enhanced the prediction of AKI progression, and mortality compared to biomarkers alone. The gene discussed is TIMP2; the disease is acute kidney injury.